Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a $257 million Series D financing co--led by investment funds managed by BlackRock and Eclipse, ...
Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...
LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...
Opportunities include the growing demand for scalable solutions to support the burgeoning cell and gene therapy pipeline, ...
Cellares, an Integrated Development and Manufacturing Organization (IDMO), announced a $257 million Series D financing co‑led ...
CAMBRIDGE, England & BAD HOMBURG, Germany--(BUSINESS WIRE)--Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that ...
Techne, bioMerieux, Roche, Lonza Group, Miltenyi Biotec India and More Cell and Gene Therapy Manufacturing QC Market Cell and ...
Cellular Origins, Resolution Therapeutics, and Cell and Gene Therapy Catapult (CGT Catapult) say they set up a project aimed at using novel technologies to deliver a hyper-efficient, fully automated, ...
Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, and Cellares Corp, the first ...
A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...
German biotechnology company Innocent Meat has secured €6 million in a new financing round to support the development of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results